Post-Doctoral Fellowship Training in HIV Clinical Investigation

艾滋病毒临床研究博士后培训

基本信息

批准号：
10649986
负责人：
Daniel W Fitzgerald
金额：
$ 9.78万
依托单位：
WEILL MEDICAL COLL OF CORNELL UNIV
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-04-01 至 2026-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10649986
关键词：
AIDS prevention Africa Appointment Area Behavioral Research Cardiovascular Diseases Caring Clinical Investigator Clinical Trials Collaborations Doctor of Pharmacy Doctor of Philosophy Fellowship Funding Goals HIV HIV Infections Human immunodeficiency virus test Hygiene Institutes Institution Intervention Studies Intervention Trial Investigation London Medical Research Outcome Patients Phase Physicians Postdoctoral Fellow Preparation Prevention Research Research Research Project Grants Research Training Schools Scientist Tanzania Training Training Programs Tropical Medicine United States National Institutes of Health Vaccine Research Women&apos s Health clinical investigation co-infection epidemiology study improved individual patient institutional capacity medical schools patient oriented patient oriented research pragmatic trial prevent programs

项目摘要

The program will strengthen patient-oriented HIV clinical investigation training of physician-scientists and other exceptional clinicians in Mwanza, in northwestern Tanzania. The program builds upon two decades of collaboration and capacity building by the partner institutions. The primary research institution in Tanzania will be the Mwanza Intervention Trials Unit (MITU), which is a unit of Tanzania’s National Institute for Medical Research (NIMR). MITU was established in 2006 as a collaboration between NIMR and the London School of Hygiene and Tropical Medicine (LSHTM) to strengthen HIV interventional research in Tanzania. MITU collaborates closely with the Weill Bugando School of Medicine, which is also located in Mwanza. Weill Bugando was established in 2003 to train physicians for northwestern Tanzania. MITU and Weill Bugando have collaborated with Weill Cornell Medical College since their founding. This research training program aims to fill a critical gap in Mwanza: the need for Tanzanian physicians with rigorous training in patient-oriented HIV clinical investigation. We use the NIH definition of clinical investigation as research which directly interacts with individual patients or clusters of patients in Phase I, II, or III clinical trials, pragmatic trials, or formative epidemiologic or behavioral research in preparation for clinical trials. The goals of the proposed training program are: 1.To increase the number of clinical investigators at MITU and thereby increase institutional capacity for HIV clinical investigation 2. Establish Weill Bugando/MITU as a sustainable training center for HIV clinical investigation. The ultimate goal is to prevent new HIV infections, provide effective HIV care, and improve HIV outcomes in Tanzania and East Africa. We will provide long-term training to fifteen outstanding clinician scientists to conduct patient-oriented HIV clinical investigation. We will primarily train physicians but will also train exceptional other clinicians (PharmD, DMD). We will train 10 PhDs, and 5 MS degree candidates. Tanzanian trainees will benefit from participation in 17 active research projects in five synergistic areas of HIV investigation including HIV prevention and vaccine research, implementation of HIV testing and treatment, women’s health, HIV related co-infections, and HIV and cardiovascular disease. We will also strengthen the PhD program in clinical investigation at Weill Bugando by introducing 4 new graduate courses in clinical investigation. Weill Cornell is committing institutional funds so that 4 of the best PhD graduates can have 2-year post-doctoral appointments as MITU research scientists after their Fogarty training. At the end of the 5-year training program, MITU will have a cadre of clinical investigators and a greater depth and breadth of externally funded HIV patient-oriented research. MITU/Weill Bugando will be a training hub for HIV clinical investigators in East Africa.

该计划将加强以患者为导向的医师科学家和艾滋病毒临床调查培训坦桑尼亚西北部姆万扎的其他杰出圣人该计划建立在二十年的基础上。坦桑尼亚的主要研究机构将开展合作和能力建设。姆万扎干预试验组 (MITU)，隶属于坦桑尼亚国家医学研究所研究 (NIMR) 成立于 2006 年，是 NIMR 和伦敦学派的合作项目。卫生和热带医学学院 (LSHTM) 加强坦桑尼亚的艾滋病毒干预研究。与同样位于姆万扎威尔的威尔布甘多医学院密切合作。 Bugando 成立于 2003 年，旨在为坦桑尼亚西北部的 MITU 和 Weill Bugando 培训医生。自威尔康奈尔医学院成立以来一直与该学院合作。该研究培训计划旨在填补姆万扎的一个关键空白：坦桑尼亚医生需要我们使用 NIH 的临床定义进行严格的以患者为导向的 HIV 临床调查培训。调查是直接与 I 期、II 期或 II 期个体患者或患者群体相互作用的研究 III 临床试验、实用试验或形成性流行病学或行为研究，为临床做准备拟议培训计划的目标是： 1. 增加临床研究人员的数量。 MITU，从而提高艾滋病毒临床研究的机构能力 2. 建立 Weill Bugando/MITU 作为艾滋病毒临床调查的可持续培训中心，最终目标是预防新的艾滋病毒。感染，提供有效的艾滋病毒护理，并改善坦桑尼亚和东非的艾滋病毒结果。我们将为十五名优秀的临床科学家提供长期培训，以进行以患者为中心的艾滋病毒治疗我们将主要培训医生，但也会培训其他特殊人员（药学博士、 DMD）。我们将培训 10 名博士生和 5 名坦桑尼亚硕士生。参与艾滋病毒调查五个协同领域的 17 个活跃研究项目，包括艾滋病毒预防和疫苗研究、艾滋病毒检测和治疗的实施、妇女健康、艾滋病毒相关的合并感染以及我们还将加强威尔临床研究方面的博士课程。威尔康奈尔致力于在布甘多开设 4 门新的临床研究研究生课程。机构基金，以便 4 名最优秀的博士毕业生能够获得为期 2 年的博士后任命 MITU 研究科学家在接受 Fogarty 培训后，在为期 5 年的培训计划结束时，MITU 将拥有一支临床研究骨干队伍和更深入、更广度的外部资助的以艾滋病患者为导向的研究 MITU/Weill Bugando 将成为东非艾滋病毒临床研究人员的培训中心。